Icotrokinra: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Icotrokinra. Educational only — not medical advice.
Labeled uses
ICOTYDE is indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.
Source: FDA labeling via NIH DailyMed (set aee3c963…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.